SuspendedNCT04099342

Enhanced Spatial Targeting in ECT Utilizing FEAST

Device studyAges 22–90United StatesDepression

The study in practice

Understand this study

What would I need to do?

You will have MRI scans.

Who could participate?

Listed age limits: 22 years to 90 years.

Listed locations: Minneapolis, United StatesSee all locations and recruitment
Activities: Device procedures described in the protocol
Compensation: Payment and expense reimbursement have not been verified.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 1, 2022

Recruitment status: Suspended
Enrollment listed in the registry: 20
Sponsor: University of Minnesota
Sponsor type: University
Study type: Device
Intervention type: DEVICE
Study phase: Not clearly listed
Locations: United States
Age range: From 22 Years to 90 Years
Official registry ID: NCT04099342
Official title: Show the full official title
Enhanced Spatial Targeting in ECT Utilizing Focally Electrically-administered Seizure Therapy (FEAST)

Need help understanding this study?

Leave your email and we’ll get in touch to discuss your questions and possible next steps.

Recruitment & locations

Suspended

Minneapolis

A listed location does not confirm current availability.

FAQ

Questions about this study

What will I need to do?

You will have MRI scans.

Who is behind this study?

The study sponsor is University of Minnesota, a university.

Who can participate?

Listed age limits: 22 years to 90 years.

Is this study still recruiting?

The registry lists this study as suspended.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me